Monday, October 24, 2011: 3:00 PM
Grand Ballroom AB (Hyatt Regency Chicago)
| Category Reference |
| BEC | Behavioral Economics |
ESP | Applied Health Economics, Services, and Policy Research |
| DEC | Decision Psychology and Shared Decision Making |
MET | Quantitative Methods and Theoretical Developments |
* Candidate for the Lee B. Lusted Student Prize Competition
Poster Board #
1
(MET)
THE OPTIMAL TIME TO PREPARE A FISTULA FOR HEMODIALYSIS PATIENTS
Steven M. Shechter, PhD, Nadia Zalunardo, MD, SM, FRCP(C) and M. Reza Skandari, PhD Student, University of British Columbia, Vancouver, BC, Canada
2
(DEC)
IMPROVING PAIN ASSESSMENT IN CLINICAL PRACTICE
Liana Fraenkel, MD, MPH, VA CT Healthcare System; Yale School of Medicine, New Haven, CT, Paul R. Falzer, PhD, VA CT Healthcare System, West Haven, CT, Terri Fried, MD, Yale School of Medicine, West Haven, CO, Minna Kohler, Yale University, New Haven, CT, Robert Kerns, PhD, VA CT Healthcare System; Yale University School of Medicine, West Haven, CT, Ellen Peters, Ph.D., Decision Research, Eugene, OR and Howard Leventhal, PhD, Rutgers University, New Brunswick, NJ
3
(DEC)
WITHDRAWN - ATTITUDES TOWARDS EUTHANASIA INFLUENCES VALUES ELICITED WITH THE TTO METHOD
Liv Ariane Augestad, MD1, Kim Rand-Hendriksen, Cand.Psychol1, Ivar Sønbø Kristiansen, MD, PhD, MPH2 and Knut Stavem, MD, MPH, PhD1, (1)Akershus University Hospital, Lørenskog, Norway, (2)University of Oslo, Oslo, Norway
4
(DEC)
A GUIDING FRAMEWORK FOR THE EVALUATION OF VALUES CLARIFICATION EXERCISES
R. Trafford Crump, Ph.D., University of Calgary, Calgary, AB, Canada and William Wedley, Ph.D., Simon Fraser University, Burnaby, BC, Canada
5
(DEC)
PSYCHIATRIC PATIENTS' ATTITUDES TOWARDS SHARED DECISION MAKING
Lilisbeth Perestelo Perez, PhD1, Carlos De las Cuevas, PhD2, Amado Rivero-Santana, PhD3, Jeanette Perez-Ramos, MPsych3, Marién Gonzalez-Lorenzo, PhD3, Juan De la Fuente, PhD4 and Emilio Sanz, PhD5, (1)Canary Islands Health Service. Ciber de Epidemiología y Salud Pública (CIBERESP), Tenerife, Spain, (2)University of La Laguna, 38004, Spain, (3)Canary Islands Foundation for Health and Research (FUNCIS), Santa Cruz de Tenerife, Spain, (4)University Hospital Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain, (5)University of La Laguna, Santa Cruz de Tenerife, Spain
7
(DEC)
INTEGRATING QUANTITATIVE PREFERENCE-RELATED EVIDENCE INTO HEALTH TECHNOLOGY ASSESSMENT: THE CASE OF VENTILATION FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Ann-Sylvia Brooker, MSc, PhD, Steven M. Carcone, MSc and Murray D. Krahn, MD, MSc, Toronto Health Economics and Technology Assessment (THETA) Collaborative, Toronto, ON, Canada
8
(DEC)
MINORITY CANCER SURVIVORS' PERCEPTIONS AND EXPERIENCE WITH CANCER CLINICAL TRIALS PARTICIPATION
Margaret M. Byrne, PhD1, Jamie L. Studts, PhD2, Susan Schmitz1, Andrea Vinard1, Martha Gonzalez1, Heraldo D'Almeida1, Colleen Bauza1, NIcole Whitehead1, Sue Stablefood3, Angela Fagerlin, PhD4 and Sarah T. Hawley, PhD, MPH5, (1)University of Miami, Miami, FL, (2)University of Kentucky College of Medicine, Lexington, KY, (3)University of New England, Portland, ME, (4)University of Michigan, Ann Arbor, MI, (5)University of Michigan, Ann Arbor VA Health System, Ann Arbor, MI
9
(DEC)
CAN HEALTH COACHING HELP PATIENTS WITH SPINAL STENOSIS MAKE AN INFORMED TREATMENT CHOICE?
Susan Berg, MS, CGC1, Sherry Thornburg, MPH2, Jon Lurie, MD1, Stephen Kearing, MS3, Kate F. Clay, MA, BSN1, William Abdu, MD1, Sohail Mirza, MD1, Harold Sox, MD4, Kevin F. Spratt, PhD1, Martha Travis-Cook1 and Dale Collins Vidal, MD, MS1, (1)Dartmouth Hitchcock Medical Center, Lebanon, NH, (2)The Dartmouth Institute, Center for Informed Choice, Lebanon, NH, (3)Dartmouth Medical School, Lebanon, NH, (4)The Dartmouth Institute, Lebanon, NH
10
(DEC)
ATTITUDES TOWARD PRENATAL TESTING AND PREGNANCY TERMINATION AMONG A DIVERSE POPULATION OF PARENTS OF CHILDREN WITH INTELLECTUAL DISABILITIES
Miriam Kuppermann, PhD, MPH1, Sanae Nakagawa, MA1, Shana Raquel Cohen, PhD2, Irenka Dominguez-Pareto, MA2, Brian L. Shaffer, MD3 and Susan D. Holloway, PhD2, (1)University of California, San Francisco, CA, (2)University of California, Berkeley, CA, (3)Oregon Health and Sciences University, Portland, OR
11
(DEC)
ASSESSING WOMEN'S SOURCES OF CHILDBIRTH INFORMATION: ARE THEY ADEQUATELY INFORMED ABOUT INDUCTION OF LABOR AND CESAREAN DELIVERY?
Anjali Kaimal, MD, MAS1, Sanae Nakagawa, MA2, Aaron B. Caughey, MD, MPP, MPH, PhD3 and Miriam Kuppermann, PhD, MPH2, (1)Massachusetts General Hospital, Harvard Medical School, Boston, MA, (2)University of California, San Francisco, San Francisco, CA, (3)Oregon Health & Sciences University, Portland, OR
12
(DEC)
TRAINING HEALTH PROFESSIONALS IN SHARED DECISION MAKING: AN INTERNATIONAL ENVIRONMENTAL SCAN
France Légaré, MD, PhD, CHUQ Research Center-Hospital St-François d'Assise, Knowledge Transfer and Health Technology Assessment, Quebec, QC, Canada, Mary Politi, PhD, Washington University School of Medicine, St. Louis, MO, Renée Drolet, PhD, Research Center of Centre Hospitalier Universitaire de Québec, Hopital St-François D'Assise, Québec, QC, Canada, Dawn Stacey, PhD, University of Ottawa, Ottawa, ON, Canada, Hilary L. Bekker, PhD, MSc, BSc, University of Leeds, Leeds, United Kingdom and CPD-SDM Group, Laval University, Québec, QC, Canada
13
(DEC)
COMPARISON OF PREFERENCE ASSESSMENT METHODS BASED ON PROSTATE CANCER PATIENT CHARACTERISTICS
Melissa S. Yale, MS1, Gregory L. Green, MPH2, Laura P. Sands, PhD1, Eunjung Lim, PhD1, David M. Latini, PhD3, Mary-Margaret Chren, MD2 and Sara J. Knight, PhD2, (1)Purdue University, West Lafayette, IN, (2)San Francisco VA Medical Center, San Francisco, CA, (3)Baylor College of Medicine, Houston, TX
14
(DEC)
PILOT SURVEY OF PHYSICAN PREFERENCES FOR TEST THRESHOLDS FOR PEDIATRIC NEUROIMAGING GUIDELINES
Carrie Daymont, MD, MSCE, University of Manitoba, Winnipeg, MB, Canada and Michael Moffatt, MD, Winnipeg Regional Health Authority, Winnipeg, MB, Canada
16
(DEC)
SURGICAL TREATMENT CONSULTATIONS WITH LUNG CANCER PATIENTS: A QUALITATIVE AND SURVEY-BASED PILOT STUDY
Joshua Hemmerich, PhD1, Mark K. Ferguson, MD1, Arthur Elstein, PhD2, Rita Gorawara-Bhat, PhD1, Cynthia Warnes, RN, BSN1, Eva Melstrom, BA1 and William Dale, MD, PhD3, (1)The University of Chicago, Chicago, IL, (2)The University of Illinois at Chicago, Wilmette, IL, (3)University of Chicago, Chicago, IL
17
(DEC)
WHAT DEFINES QUALITY IN RISK COMMUNICATION?
Jesper B. Nielsen, PhD, MSc, University of Southern Denmark,, DK-5000 Odense C, Denmark, Dorte Gyrd-Hansen, University of Southern Denmark, Odense, Denmark and Ivar Sønbø Kristiansen, MD, PhD, MPH, University of Oslo, Oslo, Norway
18
(DEC)
CAN A DECISION SUPPORT PROGRAM HELP A COHORT OF MS PATIENTS WITH DEPRESSION? IMPLEMENTATION OF A DECISION SUPPORT PROGRAM IN A MULTIPLE SCLEROSIS-PSYCHIATRIC CLINICAL MICROSYSTEM
Brant J. Oliver, NP, MPH, MSN1, Susan Berg, MS, CGC1 and Stephen Kearing, MS2, (1)Dartmouth Hitchcock Medical Center, Lebanon, NH, (2)Dartmouth Medical School, Lebanon, NH
20
(DEC)
HEALTH LITERACY, GENETIC LITERACY, AND NUMERACY IN A DIVERSE POPULATION OF PREGNANT WOMEN: IMPLICATIONS FOR PRENATAL TESTING DECISION MAKING
Anjali Kaimal, MD, MAS1, Bogdana Kovshilovskaya2, Sanae Nakagawa, MA2, Mary E. Norton, MD3 and Miriam Kuppermann, PhD, MPH2, (1)Massachusetts General Hospital, Harvard Medical School, Boston, MA, (2)University of California, San Francisco, San Francisco, CA, (3)Stanford University, Stanford, CA
22
(DEC)
ENHANCED SELF-EFFICACY REGARDING SKIN CANCER TREATMENT: THE IMPORTANCE OF INDIVIDUAL DIFFERENCE FACTORS VERSUS EXPOSURE TO A PATIENT DECISION AID
Dana L. Alden, PhD, University of Hawaii at Manoa, Honolulu, HI, Qimei Chen, PhD, University of Hawaii, Honolulu, HI and Jennifer Aaker, PhD, Standford University, Palo Alto, CA
24
(ESP)
BUDGET IMPACT OF RAPID HIV TESTING AND COUNSELING IN STD CLINICS IN THE UNITED STATES: A THRESHOLD ANALYSIS
Ashley A. Eggman, MS1, Jared A. Leff, MS1, Paco C. Castellon, MPH2, Laurel E. Hall, BS2, Erin Antunez, MS3, Tim Matheson, PhD3, Louise F. Haynes, MSW4, Susan Tross, PhD5, Lauren Gooden, MPH2, Daniel J. Feaster, PhD2, Lisa R. Metsch, PhD2, Grant N. Colfax, PhD3 and Bruce R. Schackman, PhD1, (1)Weill Cornell Medical College, New York, NY, (2)Miller School of Medicine, Miami, FL, (3)San Francisco Department of Public Health, San Francisco, CA, (4)Medical University of South Carolina, Charleston, SC, (5)Columbia University, New York, NY
25
(ESP)
ARE INDICATORS OF QUALITY CARE FOR COMORBID CONDITIONS ASSOCIATED WITH COSTS OF CARE FOR PROSTATE, BREAST, AND COLORECTAL CANCER SURVIVORS AND MATCHED CONTROLS?
Kevin D. Frick, PhD1, Claire Snyder, PhD2, Robert Herbert1, Amanda Blackford, ScM2, Bridget Neville, MPH3, Michael Carducci, MD2, Antonio Wolff, MD2 and Craig Earle, MD, MSc4, (1)Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, (2)Johns Hopkins School of Medicine, Baltimore, MD, (3)Dana-Farber Cancer Institute, Boston, MA, (4)Institute for Clinical Evaluative Sciences, Toronto, ON, Canada
27
(ESP)
DOES IT MAKE SENSE TO IDENTIFY GENETIC PREDISPOSITION IN PRIMARY PREVENTION OF COMMON ADULT DISEASE
Jennie Kempster, M.S., University of California, San Diego, Health Services Research Center, La Jolla, CA and Ted Ganiats, MD, University of California San Diego, La Jolla, CA
29
(ESP)
REFERENCE PRICING: AN INNOVATIVE BENEFIT DESIGN FOR CONTROLLING MEDICAL EXPENDITURES
Jennifer Schneider Chafen, M.D., M.S.1, Anastasia Toles, M.D., MPH2, Cathie Markow, MBA, RN2, Maeve O'Meara2 and Dena M. Bravata, MD, MS1, (1)Stanford University, Stanford, CA, (2)Castlight Health, San Francisco, CA
31
(ESP)
COST-EFFECTIVENESS OF THE MOST COMMONLY USED NON-SURGICAL TREATMENTS FOR NECK PAIN
Gabrielle van der Velde, DC, PhD1, Cesar Hincapié, DC2, Orit Schier, MSc3, Sheilah Hogg-Johnson, PhD4, Pierre Coté, DC, PhD5, Mike Paulden, MA., MSc.1 and Murray D. Krahn, MD, MSc1, (1)Toronto Health Economics and Technology Assessment (THETA) Collaborative, Toronto, ON, Canada, (2)University of Toronto Dalla Lana School of Public Health, Toronto, ON, Canada, (3)Dalla Lana School of Public Health, Toronto, ON, Canada, (4)Institute for Work & Health, Toronto, ON, Canada, (5)Toronto Western Research Institute, Toronto, ON, Canada
32
(ESP)
EIGHT YEAR COSTS OF TREATMENT FOR BREAST CANCER IN NORWAY – BY TNM STAGE AND DETECTION SETTING
Gudrun M. Waaler, M.Phil, Ivar Sønbø Kristiansen, MD, PhD, MPH, Eline Aas, Post, doc and Tron Anders Moger, Postdoc, University of Oslo, Oslo, Norway
34
(ESP)
THE MOST APPROPRIATE METHODOLOGY FOR DEALING WITH MONOTONICITY IN THE CONTEXT OF SUMMARY DATA
Matt Stevenson, PhD, The School of Health and Related Research, University of Sheffield., Sheffield, England and Nicholas Latimer, Msc, BSc, University of Sheffield, Sheffield, United Kingdom
35
(ESP)
TEST THRESHOLDS FOR OBTAINING PEDIATRIC NEUROIMAGING IN CLINICAL PRACTICE GUIDELINES
Carrie Daymont, MD, MSCE, University of Manitoba, Winnipeg, MB, Canada and Michael Moffatt, MD, Winnipeg Regional Health Authority, Winnipeg, MB, Canada
36
(ESP)
MINIMAL MODELING APPROACHES TO VALUE OF INFORMATION ANALYSIS
David Owen Meltzer, MD, PhD1, Ties Hoomans, PhD1, Jeanette W. Chung, PhD2 and Anirban Basu, PhD3, (1)University of Chicago, Chicago, IL, (2)The University of Chicago, Chicago, IL, (3)University of Washington, Seattle, WA
37
(ESP)
SYSTEMATIC REVIEW OF THE ECONOMIC AND EPIDEMIOLOGICAL BURDEN OF BLEEDING-RELATED COMPLICATIONS IN AUSTRALIA
Jonathan T. Tan, Ph.D1, Lachlan B. Standfield1 and Laurent Metz, MD, MBA, MS2, (1)Health Technology Analysts Pty Ltd, Sydney, Australia, (2)Johnson & Johnson Medical, Singapore, Singapore
38
(ESP)
MODELLING PATIENTS' PSYCHOLOGICAL CHARACTERISTICS, SELF-CARE BEHAVIOURS AND CLINICAL OUTCOMES TO INFORM A PATIENT-LEVEL SIMULATION MODEL OF DIABETES
Jen Kruger, BSc1, Alan Brennan, BSc, MSc., PhD1, Praveen Thokala, PhD1, Patrick Fitzgerald, PhD1, Rod Bond, BSc, DPhil2, Debbie Cooke, PhD3 and Marie Clark, PhD1, (1)University of Sheffield, Sheffield, United Kingdom, (2)University of Sussex, Brighton, United Kingdom, (3)University College London, London, United Kingdom
39
(ESP)
CHARACTERIZING THE UTILIZATION OF MAGNETOENCEPHALOGRAPHY IN THE DETERMINATION OF SURGICAL CANDIDACY IN CHILDREN AND ADOLESCENTS WITH MEDICALLY REFRACTORY EPILEPSY – A FIELD EVALUATION TO INFORM HEALTH POLICY
James M. Bowen, BScPhm, MSc1, O. Carter Snead III, MD, FRCPC2, Robert Hopkins, MA3, Irene Elliott, MHSc, NP, Peds, RN, (EC)4, Natasha Burke, BSc3, Jacqui Atkin4, Mara Hebbard, RN4, Laurel Brown, MHSc4, Feng Xie, PhD3, Jean-Eric Tarride, PhD, MA3, Daria J. O'Reilly, PhD, MSc3 and Ron Goeree, MA3, (1)St. Joseph's Healthcare Hamilton/McMaster University, Hamilton, ON, Canada, (2)The Hospital for Sick Children/University of Toronto, Toronto, ON, Canada, (3)McMaster University, Hamilton, ON, Canada, (4)The Hospital for Sick Children, Toronto, ON, Canada
42
(ESP)
COST-EFFECTIVENESS OF A HYPERTENSION CONTROL INTERVENTION IN THREE CHINESE COMMUNITY HEALTH CENTERS
Yamin Bai, M.S.1, Yanfang Zhao, M.S.2, Huicheng Wang, M.S.1, Kejun Liu, M.S.3, Zhong Dong, M.S.2, Xinwei Zhang, M.S.4, Ying Deng, M.S.5, Guijing Wang, PhD6 and Wenhua Zhao, M.S.1, (1)China CDC, Beijing, China, (2)Beijing CDC, Beijing, China, (3)China Ministry of Health, Beijing, China, (4)Zhejiang CDC, Zhejiang, China, (5)Sichuan CDC, Sichuan, China, (6)U.S. CDC, Atlanta, GA
44
(ESP)
COST-EFFECTIVENESS OF PULMONARY VEIN ABLATION FOR ATRIAL FIBRILLATION IN CANADA
Gordon Blackhouse, MSc.1, Nazila Assasi, MD, PhD2, Feng Xie, PhD1, Diana Robertson1, Kathryn Gaebel3, Jeff S. Healey1, Daria J. O'Reilly, PhD, MSc1, J. Tarride1 and Ron Goeree1, (1)McMaster University, Hamilton, ON, Canada, (2)St. Joseph's Healthcare/McMaster University, Hamilton, ON, Canada, (3)St Josephs Healthcare, Hamilton, ON, Canada
45
(ESP)
HOSPITAL-NURSING HOME PATIENT FLOWS DURING HURRICANE KATRINA
David H. Howard, PhD1, Kun Zhang, MA1 and E. Parker Lee, MPH2, (1)Emory University, Atlanta, GA, (2)Emory Universityh, Atlanta, GA
48
(ESP)
LANDSCAPE OF BIOLOGIC FORMULARY MANAGEMENT AND PATIENT ACCESS IN PSORIASIS
Chureen T. Carter1, Ahmad Naim1, Silas Martin1, Kathy Annunziata2 and Deborah Freedman2, (1)Centocor Ortho Biotech Services, LLC, Horsham, PA, (2)Kantar Health, New York, NY
49
(ESP)
CONSEQUENCES OF WITHDRAWING THE SECOND TUMOUR NECROSIS FACTOR α ANTAGONIST IN SEQUENTIAL TREATMENTS OF ACTIVE ANKYLOSING SPONDYLITIS: A HEALTH-ECONOMICAL PERSPECTIVE USING A POPULATION DYNAMICS SIMULATION MODEL
An Tran-Duy, PhD, Maastricht University, Maastricht, Netherlands, Annelies Boonen, PhD, Maastricht University Medical Center, Maastricht, Netherlands and Johan L. Severens, PhD, Erasmus University Rotterdam, Rotterdam, Netherlands
50
(ESP)
LONGITUDINAL ANALYSIS OF GOLIMUMAB UTILIZATION: EVIDENCE FROM THE WOLTERS KLUWER SOURCE®LX NATIONAL HEALTH CLAIMS DATABASE
Susan C. Bolge1, Lorie Ellis1, Amy Ryan2, Sara Haas2, Candace Gunnarsson2 and Neeta Tandon1, (1)Centocor Ortho Biotech Services, LLC, Horsham, PA, (2)S2 Statistical Solutions, Inc., Cincinnati, OH
51
(ESP)
DOES PQRI MAKE A DIFFERENCE?
Gay Canaris, MD, MSPH, Amy S. Neumeister, MD, Liyan Xu, MD, MS, Jane M. Carrothers, BS, MBA, Audrey Paulman, MD, MMM and Thomas G. Tape, M.D, University of Nebraska Medical Center, Omaha, NE
52
(ESP)
WITHDRAWN - AN ASSESSMENT OF THE MODIFIED RANKIN SCALE AS A STROKE OUTCOME MEASURE IN ECONOMIC ANALYSES OF ACUTE ISCHEMIC STROKE OUTCOMES
Kirsteen R. Burton, MBA, MSc, MD, University of Toronto, Toronto, ON, Canada and Dorcas E. Beaton, PhD, St. Michael's Hospital, Toronto, ON, Canada
55
(ESP)
DEVELOPING AN INTEGRATED RESEARCH PROGRAMME TO EXPLORE PATIENT BEHAVIOUR, CLINICAL OUTCOMES AND HEALTH ECONOMICS IN TYPE 1 DIABETES
Alan Brennan, BSc, MSc, PhD, Jen Kruger, BSc, Simon Heller, BA, MB, BChir, DM, FRCP and Praveen Thokala, PhD, University of Sheffield, Sheffield, United Kingdom
56
(ESP)
PSORIASIS AND PSORIATIC ARTHRITIS PATIENT PRODUCTIVITY BURDEN IN THE UNITED STATES
Chureen T. Carter1, Ahmad Naim1, Silas Martin1, Amir Goren2, Kathy Annunziata2 and Deborah Freedman2, (1)Centocor Ortho Biotech Services, LLC, Horsham, PA, (2)Kantar Health, New York, NY
57
(ESP)
GOLIMUMAB BUDGET IMPACT MODEL
Susan C. Bolge1, Stephen L. Slabaugh1, Andrea Szkurhan2, Jayson Quach2 and Neeta Tandon1, (1)Centocor Ortho Biotech Services, LLC, Horsham, PA, (2)Dymaxium, Ltd., Toronto, ON, Canada
58
(ESP)
CULTURAL VARIABILITY AMONG HISPANICS ON KNOWLEDGE OF THE HUMAN PAPILLOMAVIRUS
Julie Kornfeld, PhD1, Margaret M. Byrne, PhD1, Robin Vanderpool, DrPH2, Ian J. Bishop, BA1 and Erin Kobetz, PhD1, (1)University of Miami, Miami, FL, (2)University of Kentucky College of Public Health, Lexington, KY
60
(ESP)
OVERVIEW AND EVALUATION OF DECISION-ANALYTIC MODELS FOR THE TREATMENT OF CHRONIC MYELOID LEUKEMIA
Ursula Rochau, MD1, Ruth Schwarzer, MA, MPH, ScD1, Gaby Sroczynski, MPH, Dr.PH1, Beate Jahn, PhD1, Dominik Wolf, MD, PD2, Guenther Gastl, MD, Univ.-Prof.2 and Uwe Siebert, MD, MPH, MSc, ScD3, (1)UMIT - University for Health Sciences, Medical Informatics and Technology, ONCOTYROL - Center for Personalized Cancer Medicine, Hall i.T., Austria, (2)Medical University Innsbruck, Austria, Innsbruck, Austria, (3)UMIT-Univ. f Health Sciences;ONCOTYROL-Center f Personal. Cancer Med;Harvard School of Public Health;Harvard Med. School, Boston, Hall i.T., Austria
